Acquired hemophilia is a severe bleeding disorder that is difficult to treat. This review provides an algorithmic approach to treatment that includes emicizumab, limits hemostatic product use, and minimizes immunosuppression toxicity.

www.jthjournal.org/article/S153...

#MedSky #HemeSky